Table 8 Comparison of changes in EQ-5D-5L scores from baseline to 26 weeks after treatment between patients who received Dangguixu-san and those who received placebo for acute lateral ankle sprain (n = 23 each)
From: Effects of Dangguixu-san in patients with acute lateral ankle sprain: a randomized controlled trial
Dependent variables | Group(n) | Week 0 (M ± SD) | Week 27 (M ± SD) | Difference (w27–w0) | Z (p)a |
|---|---|---|---|---|---|
Total EQ-5D-5L | DS (n = 23) | 10.48 ± 3.06 | 5.48 ± 1.04 | − 5.00 ± 3.02 | − 0.50 (0.618) |
Placebo (n = 23) | 10.17 ± 2.61 | 5.61 ± 1.27 | − 4.57 ± 2.98 |